Besides NSCLC, KRAS mutations are also frequent in other tumor types, such as pancreatic and colorectal adenocarcinoma (88% and 50% of all cases, respectively) [28,31], with KRAS G12D mutations being the most common alteration among these histotypes (32% and 46% of all cases, respectively) [32]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.